Medical News

RSS

XerGame products to be showcased at the US Open Tennis Championships

XerTech Inc., a leading manufacturer, seller, and distributer of cutting-edge, interactive fitness systems, today announced that it will showcase its XerGame products at the US Open Tennis Championships, starting today, August 31, and running through the end of the event on September 13, 2009.

31 Aug 2009

Health care reform will kill competition in most states: BestHealthcareRates.com

Management at BestHealthcareRates.com is astonished with the government’s claims that the health care reform that they are working hard to bring about will actually encourage competition. It is much more likely that it will kill competition in most states as the giant arrives in town and takes a portion of everybody’s business.

31 Aug 2009

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

The newly formed Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare, invites interested pathology professionals to join them for the fifth annual Pathology Visions conference, to be held September 13-15 in San Diego, CA, at the Marriott Hotel and Marina.

31 Aug 2009

Walgreens to provide flue shots faster and easier this season

Walgreens (NYSE:WAG)(NASDAQ:WAG) is making it faster and easier to get a flu shot this season. The nation’s largest drugstore chain today announced it will begin offering seasonal flu shots on Sept. 1 at more than 7,000 points of care nationwide, including nearly all of its stores in 50 states and almost 350 in-store Take Care Clinics.

31 Aug 2009

Ardent Health Services selects Bravo Wellness for providing health assessment and wellness incentive services

Ardent Health Services has selected Bravo Wellness to provide health assessment and wellness incentive services to its 6,500 employees. In addition to improving employee health and productivity, the partnership has the potential to reduce the company’s overall health care costs, including out-of-pocket expenses for employees.

31 Aug 2009

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the “Best New Product” at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.

31 Aug 2009

Fernando Pisani and 24 hockey players helped raise funds and awareness about Crohn's disease and ulcerative colitis

The spirit of giving back was as strong as ever this weekend at the first ever Score for Colitis & Crohn's event, which raised $20,000 for four gastrointestinal and digestive disease patient organizations from across the country. The Score for Colitis & Crohn's initiative, which took place at the West Edmonton Mall's Ice Palace on Saturday, August 29th, featured Fernando Pisani of the Edmonton Oilers and 24 aspiring young hockey enthusiasts who were all on hand to help raise funds and awareness about Crohn's disease and ulcerative colitis, the latter of which Pisani was diagnosed with in 2007.

31 Aug 2009

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

31 Aug 2009

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

BioNeutral Group, Inc. has expanded its relationship with the Chertoff Group (Washington, DC). Beginning September 1, 2009, two senior members of the Chertoff Group will provide dedicated strategic and operational advisory services to BioNeutral to enhance the company’s strategic alliances, corporate operations, product testing, regulatory approvals, capital strategies and sales to the public and private sectors.

31 Aug 2009

Health Net urges Americans to have their blood cholesterol measured

Tomorrow, September 1, marks the start of National Cholesterol Education Month. In support of this educational effort, Health Net, Inc., (NYSE: HNT) is encouraging those who haven't yet done so, to have their blood cholesterol measured and, if it's high, to embark on a cholesterol-lowering program.

31 Aug 2009

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has filed four additional patents on its First Warning System™ methods and technology.

31 Aug 2009

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.

31 Aug 2009

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is Celladon’s consulting and management organization with clinical expertise in the development of cardiovascular products and trials.

31 Aug 2009

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company is pleased to announce that the company has signed an agreement with Leading Points Corporation to represent its products, services and initiatives to various government and military agencies.

31 Aug 2009

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

Sonomax Hearing Healthcare Inc. (SHH:TSX Venture Exchange) is proud to announce that it has successfully passed its Phase II milestone, proof-of-performance of a delivery mechanism that inflates a V3 earplug as per fit function criteria.

31 Aug 2009

New director appointed at the Saint John’s Neuroscience Institute

Saint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassam, MD, as Director of the new Saint John’s Neuroscience Institute and faculty member of the John Wayne Cancer Institute at Saint John’s. Dr. Kassam will lead the development of the new Neuroscience Institute which will offer an international minimally invasive neurosurgery center, as well as neuro-oncology, neuro-vascular surgery and other neuroscience services.

31 Aug 2009

Takeda visits managed care professionals to promote its two new drugs

According to SDI, a leading healthcare market insight and analytics firm, in spring 2009, Takeda made more visits to managed care professionals than any other pharmaceutical manufacturer, accounting for almost 7% of contacts recorded in SDI’s Managed Care Pharmacy Executive and Managed Care Medical Director audits.

31 Aug 2009

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.

31 Aug 2009

eClinicalWorks to provide its EMR solution to correctional facilities affiliated with CMS

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that the company has entered into an agreement with Correctional Medical Services, Inc. (CMS), a leading provider of health services for prisons and jails nationwide for over 30 years, to provide its electronic medical records (EMR) solution to correctional facilities affiliated with CMS.

31 Aug 2009

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into an agreement with Protein Production Services Ltd. (PPS), a leading manufacturing contractor, in order to start Good Manufacturing Practice (cGMP) production of its stem cell therapeutic product.

31 Aug 2009

Medical News

XerGame products to be showcased at the US Open Tennis Championships

Health care reform will kill competition in most states: BestHealthcareRates.com

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

Walgreens to provide flue shots faster and easier this season

Ardent Health Services selects Bravo Wellness for providing health assessment and wellness incentive services

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Fernando Pisani and 24 hockey players helped raise funds and awareness about Crohn's disease and ulcerative colitis

Merck undergoes restructuring after Schering-Plough merger

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

Health Net urges Americans to have their blood cholesterol measured

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

New director appointed at the Saint John’s Neuroscience Institute

Takeda visits managed care professionals to promote its two new drugs

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

eClinicalWorks to provide its EMR solution to correctional facilities affiliated with CMS

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News